DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Antibacterial; Antiviral are 20




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_0101Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
Mex2-81
NA
Immunoflourescence assay
Decrease (50 %)
NA
28099856
DrugRepV_0112Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
Mex2-81
NA
Immunoflourescence assay
Decrease (50 %)
NA
28099856
DrugRepV_0132Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
Mex2-81
NA
Immunoflourescence assay
Decrease (50 %)
NA
28099856
DrugRepV_0135Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
MR766
NA
Immunoflourescence assay
Decrease (95 %)
NA
28099856
DrugRepV_0136Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
MR766
NA
Immunoflourescence assay
Decrease (95 %)
NA
28099856
DrugRepV_0137Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
MR766
NA
Immunoflourescence assay
Decrease (80 %)
NA
28099856
DrugRepV_0156Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
Mex2-81
NA
Immunoflourescence assay
Decrease (95 %)
NA
28099856
DrugRepV_0157Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
Mex2-81
NA
Immunoflourescence assay
Decrease (80 %)
NA
28099856
DrugRepV_0158Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
Mex2-81
NA
Immunoflourescence assay
Decrease (90 %)
NA
28099856
DrugRepV_0183Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
Mex2-81
NA
Real-time PCR
Decrease (95 %)
NA
28099856
DrugRepV_0184Nanchangmycin
Antibacterial; Antiviral
NA
Zika virus
Mex2-81
NA
Real-time PCR
Decrease (95 %)
NA
28099856
DrugRepV_0185Nanchangmycin
Antibacterial; Antiviral
NA
Chikungunya virus
181/25
NA
Real-time PCR
Decrease (95 %)
NA
28099856
DrugRepV_0192Nanchangmycin
Antibacterial; Antiviral
NA
Chikungunya virus
Mex2-81
NA
TCID50 assay
Decrease (90 %)
NA
28099856
DrugRepV_0193Nanchangmycin
Antibacterial; Antiviral
NA
Chikungunya virus
Mex2-81
NA
TCID50 assay
Decrease (95 %)
NA
28099856
DrugRepV_0194Nanchangmycin
Antibacterial; Antiviral
NA
Chikungunya virus
Mex2-81
NA
TCID50 assay
Decrease (95 %)
NA
28099856
DrugRepV_5606Nanchangmycin
Antibacterial; Antiviral
NA
Dengue virus
New Guinea C
Pathway
Immunoflourescence assay
Decrease (95 %)
NA
28099856
DrugRepV_5607Nanchangmycin
Antibacterial; Antiviral
NA
Dengue virus
New Guinea C
Pathway
Immunoflourescence assay
Decrease (95 %)
NA
28099856
DrugRepV_5608Nanchangmycin
Antibacterial; Antiviral
NA
Dengue virus
New Guinea C
Pathway
Immunoflourescence assay
Decrease (80 %)
NA
28099856
DrugRepV_5627Nanchangmycin
Antibacterial; Antiviral
NA
Dengue virus
New Guinea C
Pathway
Real-time PCR
Decrease (95 %)
NA
28099856
DrugRepV_7004Nanchangmycin
Antibacterial; Antiviral
NA
West Nile virus
Kunjin
Pathway
Real-time PCR
Decrease (95 %)
NA
28099856